BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Strazzulla A, Coppolino G, Di Fatta C, Giancotti F, D’Onofrio G, Postorino MC, Mazzitelli M, Mammone SV, Gentile I, Rivoli L, Palella E, Gravina T, Costa C, Pisani V, De Maria V, Barreca GS, Marascio N, Focà A, Fuiano G, Gulletta E, Torti C. Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? World J Hepatol 2016; 8(19): 815-824 [PMID: 27429717 DOI: 10.4254/wjh.v8.i19.815]
URL: https://www.wjgnet.com/1948-5182/full/v8/i19/815.htm
Number Citing Articles
1
Feng Chen, Shan-Shan Wu, Chao Chen, Cheng Zhou. Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infectionsWorld Journal of Hepatology 2024; 16(2): 177-185 doi: 10.4254/wjh.v16.i2.177
2
Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti. Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antiviralsClinical and Molecular Hepatology 2018; 24(2): 151 doi: 10.3350/cmh.2017.0059
3
Ali Nada, Mohamed Abbasy, Aliaa Sabry, Azza Mohamed Abdu Allah, Somaia Shehab-Eldeen, Nada Elnaidany, Hanan Elimam, Kawthar Ibraheem Mohamed Ibraheem, Abdallah Essa. Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with SofosbuvirCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/1632959
4
Gaetano La Manna. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)Journal of Nephrology 2018; 31(2): 185 doi: 10.1007/s40620-018-0476-4
5
Yen-Chun Chen, Chen-Hao Li, Ping-Hung Ko, Chi-Che Lee, Ru-Jiang Syu, Chih-Wei Tseng, Kuo-Chih Tseng, Chen-Hua Liu. Neutrophil gelatinase-associated lipocalin partly reflects the dynamic changes of renal function among chronic hepatitis C patients receiving direct-acting antiviralsPLOS ONE 2021; 16(8): e0256505 doi: 10.1371/journal.pone.0256505